PSEN1 and Alzheimer disease: The aim of this study was to investigate cerebral metabolism during the early and late stages of cerebral amyloid pathology in the APP / presenilin-1 (PS1) knock-in (APP/PS1 KI) mouse model of AD following a closed head injury (CHI).